153 related articles for article (PubMed ID: 19784836)
1. Effects of extracellular purines on cytotoxicity of methotrexate.
Chong L; Ma G; Bartier WA; Tattersall MH
Cancer Chemother Pharmacol; 2010 May; 66(1):121-7. PubMed ID: 19784836
[TBL] [Abstract][Full Text] [Related]
2. Purine modulation of methotrexate cytotoxicity in mammalian cell lines.
Taylor IW; Slowiaczek P; Francis PR; Tattersall MH
Cancer Res; 1982 Dec; 42(12):5159-64. PubMed ID: 6958362
[TBL] [Abstract][Full Text] [Related]
3. Biochemical and cell cycle perturbations in methotrexate-treated cells.
Taylor IW; Slowiaczek P; Francis PR; Tattersall MH
Mol Pharmacol; 1982 Jan; 21(1):204-10. PubMed ID: 6982394
[TBL] [Abstract][Full Text] [Related]
4. Characterization of conditions in which dipyridamole enhances methotrexate toxicity in L1210 cells.
Muggia FM; Slowiaczek P; Tattersall MH
Anticancer Res; 1987; 7(2):161-6. PubMed ID: 3592628
[TBL] [Abstract][Full Text] [Related]
5. Critical modulation by thymidine and hypoxanthine of sequential methotrexate-5-fluorouracil synergism in murine L1210 cells.
Piper AA; Nott SE; Mackinnon WB; Tattersall MH
Cancer Res; 1983 Nov; 43(11):5101-5. PubMed ID: 6616448
[TBL] [Abstract][Full Text] [Related]
6. DNA fragmentation, dATP pool elevation and potentiation of antifolate cytotoxicity in L1210 cells by hypoxanthine.
Kwok JB; Tattersall MH
Br J Cancer; 1992 Apr; 65(4):503-8. PubMed ID: 1562458
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of ribonucleoside and deoxyribonucleoside triphosphate pools in cultured leukemia cells during exposure to methotrexate or methotrexate plus thymidine.
Kinahan JJ; Otten M; Grindey GB
Cancer Res; 1979 Sep; 39(9):3531-9. PubMed ID: 476679
[TBL] [Abstract][Full Text] [Related]
8. Osteosarcoma cells, resistant to methotrexate due to nucleoside and nucleobase salvage, are sensitive to nucleoside analogs.
Cole PD; Smith AK; Kamen BA
Cancer Chemother Pharmacol; 2002 Aug; 50(2):111-6. PubMed ID: 12172974
[TBL] [Abstract][Full Text] [Related]
9. Reversal of methotrexate inhibition of colony growth of L1210 leukemia cells in semisolid medium.
Nederbragt H; Uitendaal MP; van der Grint L; Leyva A; Pinedo HM
Cancer Res; 1981 Mar; 41(3):1193-8. PubMed ID: 6970074
[TBL] [Abstract][Full Text] [Related]
10. Effect of methotrexate and 1-beta-D-arabinofuranosylcytosine on pools of deoxyribonucleoside triphosphates in L1210 ascites cells.
Roberts D; Peck C
Cancer Res; 1981 Feb; 41(2):505-10. PubMed ID: 7448798
[TBL] [Abstract][Full Text] [Related]
11. Azidothymidine-induced cytotoxicity and incorporation into DNA in the human colon tumor cell line HCT-8 is enhanced by methotrexate in vitro and in vivo.
Tosi P; Calabresi P; Goulette FA; Renaud CA; Darnowski JW
Cancer Res; 1992 Aug; 52(15):4069-73. PubMed ID: 1638518
[TBL] [Abstract][Full Text] [Related]
12. The effects of alpha-methylene-gamma-lactone purines and pyrimidines on L1210 lymphoid leukemia nucleic acid metabolism.
Hall IH; Lee KH
Anticancer Res; 1991; 11(1):337-42. PubMed ID: 2018369
[TBL] [Abstract][Full Text] [Related]
13. Potentiation of methotrexate toxicity by dipyridamole.
Nelson JA; Drake S
Cancer Res; 1984 Jun; 44(6):2493-6. PubMed ID: 6586287
[TBL] [Abstract][Full Text] [Related]
14. [Potentiated antitumor effect of methotrexate by dipyridamole].
Cao SS
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1989 Feb; 11(1):7-12. PubMed ID: 2527632
[TBL] [Abstract][Full Text] [Related]
15. In vitro and in vivo antiproliferative activity of IPCAR, a new pyrazole nucleoside analog.
Pani A; Marongiu ME; Pinna E; Scintu F; Perra G; Montis AD; Manfredini S; La Colla P
Anticancer Res; 1998; 18(4A):2623-30. PubMed ID: 9703919
[TBL] [Abstract][Full Text] [Related]
16. Methotrexate inhibits the first committed step of purine biosynthesis in mitogen-stimulated human T-lymphocytes: a metabolic basis for efficacy in rheumatoid arthritis?
Fairbanks LD; Rückemann K; Qiu Y; Hawrylowicz CM; Richards DF; Swaminathan R; Kirschbaum B; Simmonds HA
Biochem J; 1999 Aug; 342 ( Pt 1)(Pt 1):143-52. PubMed ID: 10432311
[TBL] [Abstract][Full Text] [Related]
17. Ex vivo activity of methotrexate versus novel antifolate inhibitors of dihydrofolate reductase and thymidylate synthase against childhood leukemia cells.
Mauritz R; Bekkenk MW; Rots MG; Pieters R; Mini E; van Zantwijk CH; Veerman AJ; Peters GJ; Jansen G
Clin Cancer Res; 1998 Oct; 4(10):2399-410. PubMed ID: 9796971
[TBL] [Abstract][Full Text] [Related]
18. Biochemical and biological studies on 2-desamino-2-methylaminopterin, an antifolate the polyglutamates of which are more potent than the monoglutamate against three key enzymes of folate metabolism.
Rosowsky A; Galivan J; Beardsley GP; Bader H; O'Connor BM; Russello O; Moroson BA; DeYarman MT; Kerwar SS; Freisheim JH
Cancer Res; 1992 Apr; 52(8):2148-55. PubMed ID: 1313737
[TBL] [Abstract][Full Text] [Related]
19. Mechanism of synergistic cell killing when methotrexate precedes cytosine arabinoside: study of L1210 and human leukemic cells.
Cadman E; Eiferman F
J Clin Invest; 1979 Sep; 64(3):788-97. PubMed ID: 288743
[TBL] [Abstract][Full Text] [Related]
20. Increased thymidylate synthase in L1210 cells possessing acquired resistance to N10-propargyl-5,8-dideazafolic acid (CB3717): development, characterization, and cross-resistance studies.
Jackman AL; Alison DL; Calvert AH; Harrap KR
Cancer Res; 1986 Jun; 46(6):2810-5. PubMed ID: 2938731
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
